| |
| Issue |
Title |
| |
| Vol 10, No 6 (2014) |
«MEMORIES OF FUTURE»: CHANGE IN VERAPAMIL SIGNIFICANCE IN THE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE AND ARTERIAL HYPERTENSION |
Abstract
PDF (Rus)
|
|
S. R. Gilyarevskiy |
| |
| Vol 9, No 2 (2013) |
INTERCHANGEABILITY OF MYOCARDIAL CYTOPROTECTORS IN PATIENTS WITH ISCHEMIC HEART DISEASE. DIFFICULT QUESTIONS –SIMPLE SOLUTIONS |
Abstract
PDF (Rus)
|
|
Zh. M. Sizova |
| |
| Vol 9, No 6 (2013) |
APPLIED ASPECTS OF SLCO1B1 PHARMACOGENETIC TESTING FOR PREDICTING OF STATIN-INDUCED MYOPATHY AND PERSONALIZATION OF STATINS THERAPY |
Abstract
PDF (Rus)
|
|
D. A. Sychev, G. N. Shuev, A. B. Prokofiev |
| |
| Vol 9, No 6 (2013) |
THE ROLE OF P-GLYCOPROTEIN IN RATIONAL PHARMACOTHERAPY IN CARDIOLOGY |
Abstract
PDF (Rus)
|
|
A. V. Shulkin, E. N. Yakusheva, N. M. Popova |
| |
| Vol 10, No 6 (2014) |
IRBESARTAN IN THE CLINICAL PRACTICE |
Abstract
PDF (Rus)
|
|
V. I. Podzolkov, A. I. Tarzimanova |
| |
| Vol 10, No 6 (2014) |
СONCOMITANT ADMINISTRATION OF CLOPIDOGREL AND PROTON PUMP INHIBITORS: ARE THERE ANY OPEN QUESTIONS LEFT TODAY? |
Abstract
PDF (Rus)
|
|
S. Yu. Martsevich, A. Yu. Suvorov |
| |
| Vol 9, No 5 (2013) |
ROLE OF THE METABOLITE THERAPY FOR THE TREATMENT OF CHRONIC HEART FAILURE |
Abstract
PDF (Rus)
|
|
L. N. Maksimova, M. L. Maksimov, Y. R. Nartsissov, R. M. Zaslavskaya, E. V. Kalinina |
| |
| Vol 10, No 3 (2014) |
THE SAFETY OF STATINS: WHAT A PHYSICIAN NEEDS TO KNOW |
Abstract
PDF (Rus)
|
|
D. A. Napalkov |
| |
| Vol 10, No 3 (2014) |
OPTIMIZING THE TREATMENT OF PATIENTS WITH HYPERTENSION AND CORONARY HEART DISEASE WITH LERCANIDIPINE |
Abstract
PDF (Rus)
|
|
E. L. Trisvetova |
| |
| Vol 9, No 2 (2013) |
FIXED COMBINATION OF THE CALCIUM CHANNEL BLOCKER LERCANIDIPINE AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRIL: POSSIBILITY OF USAGE |
Abstract
PDF (Rus)
|
|
O. D. Ostroumova, I. I. Kopchenov |
| |
| Vol 10, No 4 (2014) |
NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY |
Abstract
PDF (Rus)
|
|
D. A. Napalkov, A. A. Sokolova |
| |
| Vol 10, No 4 (2014) |
EVIDENCE BASE OF ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE USE IN PATIENTS WITH STROKE AND ITS CONSEQUENCES |
Abstract
PDF (Rus)
|
|
A. D. Ehrlikh, N. A. Gratsianskii |
| |
| Vol 10, No 5 (2014) |
USE OF URAPIDIL - ANTIHYPERTENSIVE DRUG WITH DOUBLE ACTION - NEW DIRECTION IN TREATMENT OF HYPERTENSIVE CRISES |
Abstract
PDF (Rus)
|
|
V. R. Abdrakhmanov, N. I. Gaponova, N. F. Plavunov |
| |
| Vol 10, No 5 (2014) |
CHOICE OF LISINOPRIL FOR TREATMENT OF HYPERTENSION IN PATIENTS WITH CONCOMITANT DISEASES |
Abstract
PDF (Rus)
|
|
N. A. Dzhaiani |
| |
| Vol 11, No 2 (2015) |
CHRONIC KIDNEY DISEASE AND CARDIOVASCULAR DISEASES: FOCUS ON ATRIAL FIBRILLATION |
Abstract
PDF (Rus)
|
|
V. N. Shishkova |
| |
| Vol 11, No 2 (2015) |
THE EFFECTIVENESS OF LERCANIDIPINE IN REDUCING THE RISK OF ARTERIAL HYPERTENSION COMPLICATIONS |
Abstract
PDF (Rus)
|
|
E. EL. Trisvetova |
| |
| Vol 11, No 2 (2015) |
PRACTICAL ASPECTS OF APIXABAN USE IN CLINICAL PRACTICE: VIEW POINT OF CLINICAL PHARMACOLOGIST |
Abstract
PDF (Rus)
|
|
D. A. Sychev, I. I. Sinitsina, G. Yu. Zakharova, M. I. Savel'eva, A. V. Ryabova, A. V. Kryukov, A. Yu. Yurovskii |
| |
| Vol 10, No 1 (2014) |
MAGNESIUM DEFICIENCY AND CARDIOVASCULAR DISEASES: TIME TO ACT |
Abstract
PDF (Rus)
|
|
E. I. Trisvetova |
| |
| Vol 11, No 4 (2015) |
PROSPECTS FOR CYTOPROTECTORS USE IN THE ELDERLY PATIENTS THROUGH THE EXAMPLE OF CALCIFIED AORTIC STENOSIS AND ISCHEMIC HEART DISEASE |
Abstract
PDF (Rus)
|
|
N. Yu. Karpova, M. A. Rashid, N. A. Shostak, I. V. Pogonchenkova, T. V. Kazakova |
| |
| Vol 9, No 4 (2013) |
NORVASC® IN RUSSIA 20 YEARS LATER: CONTINUATION OF THE HISTORY |
Abstract
PDF (Rus)
|
|
A. V. Rudenko, B. A. Rudenko |
| |
| Vol 9, No 4 (2013) |
VARENICLINE IN PATIENTS WITH CARDIOVASCULAR DISEASES – FRIEND OR ENEMY? |
Abstract
PDF (Rus)
|
|
Yu. V. Lukina, S. Yu. Martsevich |
| |
| Vol 9, No 1 (2013) |
THE EFFICACY AND SAFETY OF DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS: AMLODIPINE PLACE |
Abstract
PDF (Rus)
|
|
M. V. Lebedeva, V. D. Beketov, N. V. Maltsev, M. E. Safarova |
| |
| Vol 11, No 3 (2015) |
THE NEW FIXED COMBINATION OF AMLODIPINE AND RAMIPRIL IN THE TREATMENT OF HYPERTENSION |
Abstract
PDF (Rus)
|
|
V. I. Podzolkov, A. I. Tarzimanova |
| |
| Vol 9, No 4 (2013) |
ACETYLSALICYLIC ACID: CONTROVERSIAL AND OUTSTANDING ISSUES |
Abstract
PDF (Rus)
|
|
E. N. Dankovtseva |
| |
| Vol 9, No 4 (2013) |
STATINS AND THE RISK OF DIABETES MELLITUS |
Abstract
PDF (Rus)
|
|
O. M. Drapkina |
| |
| Vol 11, No 1 (2015) |
ON THE SELECTION OF DRUGS DOSAGE REGIMEN |
Abstract
PDF (Rus)
|
|
E. N. Bochanova |
| |
| Vol 11, No 1 (2015) |
MYOPATHY AS A SIDE EFFECT OF STATIN THERAPY: MECHANISMS OF DEVELOPMENT AND PROSPECTS FOR TREATMENT |
Abstract
PDF (Rus)
|
|
O. M. Drapkina, E. M. Chernova |
| |
| Vol 9, No 1 (2013) |
LERCANIDIPINE, CALCIUM CHANNEL BLOCKER OF THE THIRD GENERATION: NEW POSSIBILITIES IN THE TREATMENT OF ARTERIAL HYPERTENSION |
Abstract
PDF (Rus)
|
|
O. D. Ostroumova, M. L. Maksimov, I. I. Kopchenov |
| |
| Vol 9, No 3 (2013) |
PROBLEMS AND PROSPECTS OF INTERMEDIARY METABOLISM CORRECTION IN PATIENTS WITH VASCULAR COMORBIDITY |
Abstract
PDF (Rus)
|
|
S. A. Rumyantseva, R. G. Oganov, V. A. Stupin, E. V. Silina, A. S. Orlova, S. B. Bolevich, V. V. Afanasev, E. N. Kabaeva, S. A. Volik |
| |
| Vol 10, No 2 (2014) |
ADVANTAGES OF COMBINATION THERAPY OF HYPERTENSION WITH CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN-CONVERTING ENZYME INHIBITOR IN PATIENTS WITH IMPAIRED RENAL FUNCTION |
Abstract
PDF (Rus)
|
|
N. A. Dzhaiani |
| |
| Vol 9, No 3 (2013) |
TRUE RESISTANCE AND PSEUDORESISTANCE TO ASPIRIN |
Abstract
PDF (Rus)
|
|
A. I. Martynov, E. V. Akatova, I. V. Urlayeva, O. P. Nicolin |
| |
| Vol 9, No 3 (2013) |
STATINS AND RISK OF INFECTIOUS DISEASES |
Abstract
PDF (Rus)
|
|
O. M. Drapkina, R. N. Shepel' |
| |
| Vol 9, No 3 (2013) |
CLINICAL SIGNIFICANCE OF DRUGINDUCED INTERVALS QT AND QTC PROLONGATION |
Abstract
PDF (Rus)
|
|
N. V. Furman, S. S. Shmatova |
| |
| 201 - 233 of 233 Items |
<< < 1 2 3
|
